
|Articles|December 13, 2007
Trilostane: A new treatment option for dogs with hyperadrenocorticism (1:40)
Author(s)David S. Bruyette, DVM, DACVIM
"The advantage of trilostane seems to be a much higher safety profile than Lysodren with an equal efficacy rate."
Advertisement
Advertisement
Latest CE
Advertisement
Advertisement
Trending on dvm360
1
AAHA releases new diabetes management guidelines for dogs
2
Multiple chronic diseases compound to shorten dogs' lifespans, study finds
3
How freeze-dried plasma research could pave the way for innovative synthetic blood products
4
FDA emergency authorizes Capstar, generic nitenpyram to prevent and treat New World screwworm in dogs and cats
5






